Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
New investigational drugs with single-agent activity in multiple myeloma
A. M. Rajan,
S. Kumar
Hematology
Research output
:
Contribution to journal
›
Review article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New investigational drugs with single-agent activity in multiple myeloma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Investigational Drugs
100%
filanesib
77%
Multiple Myeloma
70%
venetoclax
56%
Proteasome Inhibitors
42%
isatuximab
36%
ONX 0912
35%
dinaciclib
34%
marizomib
33%
elotuzumab
32%
ixazomib
31%
daratumumab
30%
Panobinostat
28%
Kinesin
22%
Cyclin-Dependent Kinases
20%
Phosphotransferases
13%
Monoclonal Antibodies
13%
Clinical Trials
11%
Therapeutics
8%
Pharmaceutical Preparations
7%
Proteins
6%
Neoplasms
5%